|
1
|
Tamara P: Tourette syndrome and other tic
disorders of childhood. Handb Clin Neurol. 112:853–856. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cheung MY, Shahed J and Jankovic J:
Malignant tourette syndrome. Mov Disord. 22:1743–1750. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lv W, Li WY, Xu XY, Jiang H and Bang OY:
Bone marrow mesenchymal stem cells transplantation promotes the
release of endogenous erythropoietin after ischemic stroke. Neural
Regen Res. 10:1265–1270. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Choi HS, Kim HJ, Oh JH, Park HG, Ra JC,
Chang KA and Suh YH: Therapeutic potentials of human
adipose-derived stem cells on the mouse model of Parkinson's
disease. Neurobiol Aging. 36:2885–2892. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu X, Wang Y, Li D and Ju X:
Transplantation of rat neural stem cells reduces stereotypic
behaviors in rats after intrastriatal microinfusion of Tourette
syndrome sera. Behav Brain Res. 186:84–90. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu XM, Wang YW and Yi MJ: Effects of
human mesenchymal stem cell transplantation in the bilateral corpus
striatum in a rat model of Tourette's syndrome. Neural Regen Res.
5:1285–1290. 2010.
|
|
7
|
van Velthoven CT, Braccioli L, Willemen
HL, Kavelaars A and Heijnen CJ: Therapeutic potential of
genetically modified mesenchymal stem cells after neonatal
hypoxic-ischemic brain damage. Mol Ther. 22:645–654. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu X, Wang X, Li L, Wang H and Jiao X:
Influence of mesenchymal stem cell transplantation on stereotypic
behavior and dopamine levels in rats with Tourette syndrome. PLoS
One. 8:e621982013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen A, Xiong LJ, Tong Y and Mao M: The
neuroprotective roles of BDNF in hypoxic ischemic brain injury.
Biomed Rep. 1:167–176. 2013.PubMed/NCBI
|
|
10
|
Hornig M and Lipkin WI: Immune-mediated
animal models of Tourette syndrome. Neurosci Biobehav Rev.
37:1120–1138. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Singer HS, Loiselle CR, Lee O, Minzer K,
Swedo S and Grus FH: Anti-Basal Ganglia Antibodies in PANDAS. Mov
Disord. 19:406–415. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Macri S, Onori MP, Roessner V and Laviola
G: Animal models recapitulating the multifactorial origin of
Tourette syndrome. Int Rev Neurobiol. 112:211–237. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Taylor JL, Rajbhandari AK, Berridge KC and
Aldridge JW: Dopamine receptor modulation of repetitive grooming
actions in the rat: Potential relevance for Tourette syndrome.
Brain Res. 1322:92–101. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Malaty IA and Akbar U: Updates in medical
and surgical therapies for Tourette syndrome. Curr Neurol Neurosci
Rep. 14:4582014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Phinney DG and Isakova IA: Mesenchymal
stem cells as cellular vectors for pediatric neurological
disorders. Brain Res. 1573:92–107. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang F, Wang YY, Liu H, Lu YF, Wu Q, Liu
J and Shi JS: Resveratrol produces neurotrophic effects on cultured
dopaminergic neurons through prompting astroglial BDNF and GDNF
release. Evid Based Complement Alternat Med. 2012:9376052012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kordi-Tamandani DM, Sahranavard R and
Torkamanzehi A: DNA methylation and expression profiles of the
brain-derived neurotrophic factor (BDNF) and dopamine transporter
(DAT1) genes in patients with schizophrenia. Mol Biol Rep.
39:10889–10893. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ferrini F and De Koninck Y: Microglia
control neuronal network excitability via BDNF signalling. Neural
Plast. 2013:4298152013.PubMed/NCBI
|
|
19
|
Paulsen JS: Cognitive impairment in
Huntington disease: Diagnosis and treatment. Curr Neurol Neurosci
Rep. 11:474–483. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shimada H, Makizako H, Doi T, Yoshida D,
Tsutsumimoto K, Anan Y, Uemura K, Lee S, Park H and Suzuki T: A
large, cross-sectional observational study of serum BDNF, cognitive
function and mild cognitive impairment in the elderly. Front Aging
Neurosci. 6:692014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li Y, Yui D, Luikart BW, McKay RM, Li Y,
Rubenstein JL and Parada LF: Conditional ablation of brain-derived
neurotrophic factor-TrkB signaling impairs striatal neuron
development. Proc Natl Acad Sci USA. 109:15491–15496. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Niitsu T, Shirayama Y, Matsuzawa D,
Hasegawa T, Kanahara N, Hashimoto T, Shiraishi T, Shiina A, Fukami
G, Fujisaki M, et al: Associations of serum brain-derived
neurotrophic factor with cognitive impairments and negative
symptoms in schizophrenia. Prog Neuropsychopharmacol Biol
Psychiatry. 35:1836–1840. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mang CS, Campbell KL, Ross CJ and Boyd LA:
Promoting neuroplasticity for motor rehabilitation after stroke:
Considering the effects of aerobic exercise and genetic variation
on brain-derived neurotrophic factor. Phys Ther. 93:1707–1716.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Martino D, Chiarotti F, Buttiglione M,
Cardona F, Creti R, Nardocci N, Orefici G, Veneselli E and Rizzo R:
Italian Tourette Syndrome Study Group: The relationship between
group A streptococcal infections and Tourette syndrome: A study on
a large service-based cohort. Dev Med Child Neurol. 53:951–957.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yeh TK, Hu CY, Yeh TC, Lin PJ, Wu CH, Lee
PL and Chang CY: Association of polymorphisms in BDNF, MTHFR, and
genes involved in the dopaminergic pathway with memory in a healthy
Chinese population. Brain Cogn. 80:282–289. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Binder DK, Croll SD, Gall CM and Scharfman
HE: BDNF and epilepsy: Too much of a good thing? Trends Neurosci.
24:47–53. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Denys D, de Vries F, Cath D, Figee M,
Vulink N, Veltman DJ, van der Doef TF, Boellaard R, Westenberg H,
van Balkom A, et al: Dopaminergic activity in Tourette syndrome and
obsessive-compulsive disorder. Eur Neuropsychopharmacol.
23:1423–1431. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Stagg J and Galipeau J: Mechanisms of
immune modulation by mesenchymal stromal cells and clinical
translation. Curr Mol Med. 13:856–867. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Brennen WN, Denmeade SR and Isaacs JT:
Mesenchymal stem cells as a vector for the inflammatory prostate
microenvironment. Endocr Relat Cancer. 20:R269–R290. 2013.
View Article : Google Scholar : PubMed/NCBI
|
